Mutations of DNMT3A are frequently observed in different hematological malignancies, including AML (both adult and pediatric), T-cell acute lymphoblastic leukemia (T-ALL), myelodysplastic syndrome (MDS), and T-cell lymphomas (TCL) (131). This evidence concerns the gene DNMT3A and acute myeloid leukemia.